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ABSTRACT
Selenoproteins contain the amino acid selenocys-
teine which is encoded by a UGA Sec codon.
Recoding UGA Sec requires a complex mechanism,
comprising the cis-acting SECIS RNA hairpin in the
3’UTR of selenoprotein mRNAs, and trans-acting
factors. Among these, the SECIS Binding Protein 2
(SBP2) is central to the mechanism. SBP2 has been
so far functionally characterized only in rats and
humans. In this work, we report the characterization
of the Drosophila melanogaster SBP2 (dSBP2).
Despite its shorter length, it retained the same
selenoprotein synthesis-promoting capabilities
as the mammalian counterpart. However, a major
difference resides in the SECIS recognition
pattern: while human SBP2 (hSBP2) binds the dis-
tinct form 1 and 2 SECIS RNAs with similar affinities,
dSBP2 exhibits high affinity toward form 2 only. In
addition, we report the identification of a K (lysine)-
rich domain in all SBP2s, essential for SECIS and
60S ribosomal subunit binding, differing from the
well-characterized L7Ae RNA-binding domain.
Swapping only five amino acids between dSBP2
and hSBP2 in the K-rich domain conferred
reversed SECIS-binding properties to the proteins,
thus unveiling an important sequence for form 1
binding.
INTRODUCTION
Selenoproteins are a diverse family of proteins character-
ized by the presence of the 21st amino acid selenocysteine
(Sec). This amino acid is co-translationally incorporated
into the growing peptide chain in response to a UGA Sec
codon, otherwise read as a signal for termination of trans-
lation. In eukaryotes, the correct recoding event of UGA
stop to UGA Sec relies on speciﬁc, conserved RNA struc-
tures and proteins. The tRNA
Sec and the SECIS element,
an RNA hairpin in the 30UTR of selenoprotein mRNAs,
and two trans-acting proteins, the specialized translation
elongation factor eEFSec and the SECIS Binding Protein
2 (SBP2), are the key players of the recoding machinery
(1). Specialized protein complexes that involve SECp43,
the Phosphoserine tRNA
Sec Kinase (PSTK) and the Sec
synthase are recruited to the tRNA
Sec to ensure proper
selenocysteine synthesis (2–4). Ribosomal protein L30
has also been implicated in this mechanism and shown
to compete with SBP2 for SECIS binding (5).
There are two types of functional SECIS RNAs, forms
1 and 2, classiﬁed according to their diﬀerent apex: form 2
has an additional helix, and its apical loop is shorter than
in form 1 (6,7). Structure-based alignments in the cur-
rently available eukaryotic selenoproteome identiﬁed
form 2 SECIS as the most widespread element (8).
Except for the apex, SECIS RNA hairpins share
common structural features, in particular four consecutive
non-Watson–Crick base pairs (the quartet) composed of a
central tandem of sheared G.A/A.G base pairs (7–10).
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(kink)-turn motifs which are recurrent in a variety of
RNAs (11–13). The SECIS RNA has been proposed to
contain a K-turn like motif (14) that is essential for SBP2
interaction and selenoprotein incorporation in vivo (10).
A number of proteins fulﬁlling diﬀerent functions such
as snRNPs, snoRNPs or ribosomal proteins bind K-turn
RNA motifs (15,16). They all carry the L7Ae RNA-bind-
ing domain (or module) (17) that contains a restricted set
of amino acids that establish base-speciﬁc contacts with
the sheared G.A/A.G base pairs (11,18,19).
SBP2 also has the L7Ae module in its RNA-binding
domain (20–22). In an earlier work, we predicted the
human SBP2 (hSBP2) amino acids that contact the
SECIS RNA at the K-turn like motif (20). However,
while sharing some RNA-binding properties with other
proteins of the L7Ae family, SBP2 possesses its own spe-
ciﬁcities (23). The known functions of SBP2, comprising
SECIS and ribosome binding, and Sec incorporation,
reside in the C-terminal two-thirds of the protein
(21,22,24). However, no function has been attributed to
the remaining N-terminal section which has been shown to
be dispensable for Sec incorporation in rabbit reticulocyte
lysate (25).
Selenoproteins exist in the three domains of life.
Vertebrate genomes encode up to 25–26 selenoproteins
but surprisingly larger selenoproteomes can be found in
aquatic unicellular organisms (26). Only three selenopro-
tein genes have been discovered in Drosophila melanoga-
ster, SPS2, SelH and SelK (27,28). SPS2 is the
selenophosphate synthetase involved in selenocysteine bio-
synthesis. SelH and SelK are poorly characterized func-
tionally but they seem nevertheless to play an antioxidant
role (29,30). In each case however, only form 2 SECIS
RNAs were found in the 30UTR of the selenoprotein
mRNAs.
Some of us have recently published the annotation
and multiple sequence alignments of insect selenoprotein
synthesis factors, especially in 12 Drosophila genomes (31).
Among these factors, our attention was attracted by
the putative Drosophila SBP2 because they lack the
sequence homologous to the N-terminus of hSBP2.
Although a number of SBP2 sequences from mammals,
non-mammalian vertebrates or even unicellular organisms
are annotated in databases, only the rat and hSBP2 have
been so far isolated and functionally characterized
(20–25,32,33). This prompted us to study Drosophila
SBP2s and in particular Drosophila melanogaster. In this
work, we report that despite its shorter length, D. melano-
gaster SBP2 (dSBP2) retains functional properties similar
to its mammalian counterpart. However, dSBP2 exhibits
selective aﬃnities toward SECIS RNAs, being almost
unable to bind form 1 SECIS. We determined that the
discriminating amino acids reside in a K (lysine)-rich
region that we also identiﬁed in hSBP2 as essential for
SECIS RNA binding. In addition we showed that, in
hSBP2, mutating the K-rich region aﬀected form 1 and
form 2 SECIS interaction diﬀerently, and that this
region also plays a crucial role in 60S ribosomal subunit
binding.
MATERIALS AND METHODS
Strainsand growth conditions
The Escherichia coli TG2 strain was used as the host strain
for plasmid construction. Growth was performed at 378C
in LB medium, complemented with 100mg/ml ampicillin.
The E. coli strain BL21(DE3)-star was used for produc-
tion of Drosophila SBP2 proteins at 258C in ZYM-5052
auto-induction medium as described by Studier et al. (34).
The E. coli strain BL21(DE3)RIL (Novagen) was used for
production of hSBP2 proteins at 188C in LB medium.
Bioinformatic analyses
Alignment of human/pig/rat/insect SBP2s. Annotated
SBP2 sequences from human (gb|AAK57518.1|AF38
0995), rat (sp|Q9QX72.1|SEBP2_RAT), pig (ef|XP_0019
28402.1) and chicken (ref|XP_424425.2|) were aligned
against the putative SBP2 sequences found in three
Drosophila species, D. melanogaster, D. pseudoobscura
and D. sechelia (31) by Kalign (35).
Alignment of the K-rich domain. All annotated members
of the SBP2 family in Ensembl (ENSF00000007674) were
extracted and all those with no ‘X’ in the relevant region
were kept. The search was extended by blasting the
D. melanogaster SBP2 against the nr database of NCBI.
Of the resulting hits, only those containing the IHSRRF
motif (positions 624–629 in hSBP2) characteristic of SBP2
proteins (C.A and A.K., unpublished data) were kept. We
subsequently used the L7Ae RNA-binding module of
SBP2 (33) to query the nr database using Hmmer (36).
Finally, we also added the insect SBP2 sequences (31).
The resulting 40 sequences were aligned using maﬀt (37).
The alignment images shown in Figures 1 and 7 were
produced by Jalview (38).
cDNA cloning andrecombinant DNA
Drosophila melanogaster SBP2 ORF (Genebank accession
# AI062219) was ampliﬁed from pOT2 cDNA clone
GH01354 (Research Genetics) in a two-step PCR reaction
and introduced into the pHMGWA vector (39) using the
Gateway Technology (Invitrogen). The resulting
pHMdSBP2 vector contains a 6  His-tag and Maltose-
Binding Protein coding-frame upstream of the dSBP2
ORF and allows E. coli expression of the protein.
Human SBP2 ORF was ampliﬁed by PCR from plasmid
pA11 (33) and subsequently cloned into pET32b
(Novagen), generating phSBP2-FL (full-length), as well
as plasmids encoding the N-terminal truncated proteins
phSBP2 344–854, phSBP2 399–854, phSBP2 515–854,
phSBP2 525–854, phSBP2 545–854, phSBP2 625–854
and phSBP2 674–854, and C-terminal truncated proteins
phSBP2 344–674, phSBP2 344–790 and phSBP2 344–820.
Alanine scanning mutants in hSBP2 were generated
in phSBP2 344–854 using the Kunkel mutagenesis
method (40). Amino acids swapping mutants exchanging
hSBP2 aa535–539 for dSBP2 aa95–99 (phSBP2-SVRVY)
and dSBP2 aa95–99 for hSBP2 aa535–539 (pdSBP2-
IILKE), were generated by site-directed mutagenesis
of phSBP2 344–854 and pHMdSBP2, respectively,
Nucleic Acids Research,2009, Vol.37, No. 7 2127using the QuickChange XL Site-Directed Mutagenesis
kit (Stratagene) according to the manufacturer’s
instructions.
Plasmids pT7SelN, pT7GPx1 and pT7PHGPx were
used for T7 transcription of human SelN, rat GPx1 and
PHGPx SECIS RNAs, respectively (7,9). To allow in vitro
transcription of Drosophila SECIS RNAs, D. melanoga-
ster SelK and SelH SECIS elements were PCR ampliﬁed
from pOT2 cDNA clones GH03581 and SD09114, respec-
tively (generously provided by M. Corominas, University
of Barcelona) and introduced into the BclI-EcoRI sites of
pT7-Bck vector (9) to create pT7dSelK and pT7dSelH.
A point mutant in dSelH SECIS (dSelHmut), and the
SECIS RNA apex-swapped mutants PHGPx-ApSelN
and SelN-ApPHGPx SECIS RNAs, were generated by
site-directed mutagenesis of pT7dSelH, pT7PHGPx and
pT7SelN, respectively, using the QuickChange XL Site-
Directed Mutagenesis kit.
To generate selenoprotein mRNA reporter constructs
for in vitro translation assays, D. melanogaster SelH
ORF and 30UTR (Genebank accession #AI542675) were
ampliﬁed from pOT2 cDNA clone SD09114 and cloned
into the HindIII-KpnI sites of the pXJ(HA)3 eukaryotic
expression vector (41) to create pHAdSelH. Rat seleno-
protein reporter constructs pGPx1-GPx1SECIS and
pGPx1-SECIS were as described in (10). To create
pGPx1-PHGPxSECIS and pGPx1-SelNSECIS, the GPx1
SECIS element of the pGPx1-GPx1SECIS reporter con-
struct was exchanged for PHGPx and SelN SECIS ele-
ments from pT7PHGPx and pT7SelN, respectively,
using BclI-EcoRI sites.
Oligonucleotides used for PCR and mutagenesis are
listed in Supplementary Data.
Recombinant proteinpreparation
Drosophila SBP2 recombinant proteins expressed in E. coli
were puriﬁed using Amylose Resin column (NEB). 6  His
and MBP tags were cleaved from the dSBP2 protein by
thrombin (Sigma) when used for electrophoretic mobility
shift assays. hSBP2 recombinant proteins expressed in
E. coli were puriﬁed using Ni-NTA agarose (Qiagen).
Elution buﬀer was exchanged to dialysis buﬀer containing
20mM Tris–HCl pH 7.5, 100mM NaCl, 10mM MgCl2,
20% glycerol, 1mM DTT and Cocktail inhibitor (Sigma).
Electrophoretic mobility shift assay
Plasmids yielding PHGPx, SelN, GPx1, dSelK, dSelH,
dSelHmut, PHGPx-ApSelN and SelN-ApPHGPx SECIS
RNAs were linearized by EcoRI. Internally labeled SECIS
RNAs were obtained by T7 transcription using 80mCi of
[a-
32P]-ATP (3000Ci/mmol). SECIS RNA-SBP2 com-
plexes were formed as described in (20). Routinely,
30000 cpm of
32P-labeled SECIS RNA were incubated
for 30min at 308C with various concentrations of puriﬁed
SBP2 protein (from 0 to 2000nM), in 7.5ml of phosphate
buﬀer saline pH 7.4, 2mM DTT. RNA–protein complexes
were separated on 6% non-denaturing polyacrylamide gel
electrophoresis in 0.5  TBE, 5% glycerol buﬀer. The
intensities of free and bound RNAs were quantitated
with the Fujiﬁlm FLA-5100 Imaging system. Kds were
determined from three independent experiments.
In vitro selenoprotein synthesis assays
In vitro translation of Drosophila (dSelH) or rat GPx1
from selenoprotein encoding plasmids carrying (or lack-
ing) wild-type SECIS elements were performed using TNT
Coupled Reticulocyte Lysate Systems (Promega). One
microgram of each of the selenoprotein plasmid DNA
was used as the template in 50ml in vitro transcription/
translation reactions in the presence of 25ml rabbit reticu-
locyte lysate, 20mCi of
35S-methionine and 120–240nM
of puriﬁed SBP2 protein. In vitro translated HA-tagged
dSelH and hGPx1 proteins were puriﬁed using
microMACS Epitope Tag Protein Isolation Kits
(Miltenyi Biotec), resolved by 10% SDS–PAGE and
detected with the Fujiﬁlm FLA-5100 Imaging system.
Quantiﬁcation of selenoprotein synthesis was performed
from two to three independent experiments.
Ribosome-binding assays
60S and 40S ribosomal subunits were isolated from full
term human placenta according to ref. (42). Human
recombinant ribosomal protein p40 was a kind gift of
Dr Alexey Malygin (ICBFM, Novosibirsk, Russia).
Monoclonal antibodies against human p40 were provided
by Dr Valery Loktev. Binding mixtures (50ml) containing
30pmol of 60S or 40S subunits were reactivated at 378C
for 10min in PBSD buﬀer (150mM NaCl, 27mM KCl,
8mMNa 2HPO4, 1.7mM KH2PO4 and 2mM DTT) con-
taining 0.5mM MgCl2. Then 3.5mg SBP2 (or SBP2
mutants) or 2mg ribosomal protein p40 were added and
incubated at 228C for 20min. The mixtures were loaded
onto a 15–30% linear sucrose gradient in PBSD with
0.5mM Mg
2+ and centrifuged in a SW41 rotor at
23000rpm for 15h. Fractions corresponding to 60S and
40S subunits were precipitated by 10% trichloroacetic
acid, and the pellet content loaded onto 10% SDS–
PAGE which was blotted onto nitrocellulose membranes.
SBP2 was detected with an anti-SBP2 polyclonal antibody
(1/5000–1/10000 dilution) in PBST (1  PBS containing
0.1% Tween 20, 3% dry milk), p40 with a monoclonal
anti-p40 (1/3000 dilution). Membranes were treated with
anti-rabbit HRP-conjugated secondary antibody (1/10000
dilution), revealed with the ECL plus kit (GE HealthCare)
and exposed to either X-ray ﬁlm or ChemDoc XRS.
RESULTS
Identification andfunctional characterization ofdSBP2
Recent comparative analysis of insect genomes have
identiﬁed putative SBP2 proteins (31). In this work we
set out to clone and characterize dSBP2 and compare it
to hSBP2. tBlastn searches were performed at NCBI using
the hSBP2 amino acid sequence (33) and one signiﬁcant
hit (AI062219) was obtained with a D. melanogaster
sequence predicted to encode a 313 amino-acid protein.
Figure 1 shows a multiple sequence alignment of this pro-
tein as well as other putative SBP2 from D. pseudoobscura
2128 Nucleic Acids Research, 2009, Vol. 37,No. 7Figure 1. Alignment of SBP2 proteins. Drosophila (pseudoobscura, melanogaster and sechelia) SBP2 sequences were from (31). Accession numbers for
vertebrate SBP2 are XP_424425.2| (chicken), Q9QX72.1 (rat), XP_001928402.1 (Sus scrofa), AF380995 (human). The color scheme above the
sequences is explicited at the bottom of the ﬁgure.
Nucleic Acids Research,2009, Vol.37, No. 7 2129and D. sechelia (31) with the characterized rat and human
SBP2 (25,33) and the annotated chicken and Sus scrofa
SBP2s. Strikingly, the three putative Drosophila SBP2s
lack homology to the vertebrate SBP2 N-terminal
region. Homologies to vertebrate SBP2s were found
throughout the rest of the sequence, starting from
hSBP2 residue 427. Two blocks of high sequence identity
were detected, one extending from K517 to K544, the
other from I624 to K774 (hSBP2 numbering), with 50%
and 36% identity, respectively. The latter block contains
the previously identiﬁed L7Ae RNA-binding module
spanning residues R672 to I749 (21,22).
To verify that the D. melanogaster cDNA encodes a
bona ﬁde SBP2, it was cloned and expressed in E. coli
and assayed for SECIS RNA binding. Gel shift assays
were performed with the form 2 SECIS RNAs of the
dSelK and SelH mRNAs (dSelK and dSelH SECIS
RNAs), showing formation of dSBP2–dSECIS RNA
complexes (Figure 2A, lanes 2–8 and 10–16). Kd values
were 260nM and 170nM for dSelK SECIS and dSelH
SECIS RNAs, respectively, indicating a slightly higher
aﬃnity for dSelH SECIS RNA. To determine whether
the binding was speciﬁc, we used a mutant SECIS RNA
(dSelHmut SECIS, Figure 2A) in which the conserved U
in the non-Watson–Crick quartet was replaced by a C, a
mutation that impedes hSBP2 binding (43). Figure 2A
(lanes 18–25) showed that no retarded complex was
obtained, the band marked by an asterisk containing an
RNA conformer also present in the control lane 17 (see
also lane 9) but not an RNA–protein complex. We there-
fore concluded that dSBP2 bound speciﬁcally to the cog-
nate SECIS RNAs.
We next investigated whether dSBP2 could support sele-
noprotein synthesis. To this end, rabbit reticulocyte lysate
was used to synthesize D. melanogaster selenoprotein SelH
(dSelH) from a reporter construct. The advantage of such
SECIS RNA
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Figure 2. Functional characterization of dSBP2. (A) Electrophoretic mobility shift assays were performed between the puriﬁed dSBP2 and the in vitro
transcribed
32P-labeled form 2 SECIS RNAs (dSelK SECIS and dSelH SECIS) from Drosophila SelK and SelH selenoprotein mRNAs. Increasing
concentrations (75–2000nM) of dSBP2 were added. A dSeH mutant SECIS RNA (dSelHmut), carrying a U to C mutation in the non-Watson-Crick
quartet, abolished the binding of dSBP2. dSBP2 was omitted in the control lanes 1, 9 and 17 ( ). The asterisk denotes the position of a band that is
also present in the control lanes 9 and 17. It often occurs and presumably contains an RNA conformer arising from T7 transcription. (B) dSBP2 can
support selenoprotein H (dSelH) synthesis in rabbit reticulocyte lysate. Synthesis of full-length (
35S)-Met-labeled selenoprotein dSeH was obtained by
adding puriﬁed dSBP2 (lane 1) or hSBP2 (lane 2) to the lysate. Lane 3: absence of SBP2 led to premature termination of translation (Truncated).
Translation products were immunopuriﬁed and resolved by SDS–PAGE.
2130 Nucleic Acids Research, 2009, Vol. 37,No. 7an extract is that it contains all the components required
for selenoprotein mRNA translation but lacks SBP2
which must be added to obtain a full-length selenoprotein
(25). Figure 2B (lane 3) showed that omission of SBP2
resulted in the synthesis of a truncated dSelH selenopro-
tein arising from premature termination of translation at
the UGA Sec codon. Full-length dSelH could be obtained
only upon addition of dSBP2 (Figure 2B, lane 1), in much
the same way as hSBP2 (hSBP2; Figure 2B, lane 2). The
truncated form of dSelH ending at the UGA Sec codon
(lanes 1 and 2) very likely originated from saturation of
the selenoprotein synthesis machinery in the reticulocyte
lysate.
Overall, our data established that we have identiﬁed and
functionally characterized the dSBP2 protein which pos-
sesses the same selenoprotein synthesis capacities as the
human counterpart.
dSBP2manifests distinctive SECIS RNA-binding activities
The abilities of dSBP2 to bind various SECIS RNAs were
further investigated and compared to hSBP2. Form 2
SECIS, the only type of SECIS found in Drosophila
(31), were tested ﬁrst. Figure 3 and Table 1 show that
complexes were obtained between the SECIS of the rat
PHGPx (phosphohydroxylipid glutathione peroxidase)
mRNA and dSBP2 (Figure 3A, lanes 2–7; Kd=220nM)
or hSBP2 (Figure 3A, lanes 23–29; Kd=320nM).
Additionally, hSBP2 also bound dSelH and dSelK
SECIS RNAs (data not shown). Major diﬀerences
appeared when form 1 SECIS was tested (a schematic
drawing of SECIS forms 1 and 2 is shown in the inset of
Figure 4). While hSBP2, as expected, bound readily the
SECISes of the rat GPx1 (glutathione peroxidase 1) and
human SelN (selenoprotein N) mRNAs (Figure 3A, lanes
31–37 and 39–45), dSBP2 only weakly recognized the SelN
SECIS and was unable to bind the GPx1 SECIS at all
(Figure 3A, lanes 16–21 and 9–14). These ﬁndings were
corroborated by selenoprotein synthesis experiments in
reticulocyte lysate in which dSBP2 enabled synthesis of
a selenoprotein reporter (rat GPx1) from an mRNA car-
rying a form 2 PHGPx but not a form 1 GPx1 SECIS in
the 30UTR (Figure 3B, compare lanes 2, 3 with lanes 7, 8).
Synthesis from the form 1 SelN SECIS-containing repor-
ter was weak (Figure 3B, lanes 12, 13), in keeping with the
low aﬃnity to SelN SECIS. In contrast, hSBP2 led to
synthesis of GPx1 regardless of the type of SECIS har-
bored by the reporter mRNA (Figure 3B, lanes 4, 5, 9, 10,
14, 15). Control experiments with a GPx1-SECIS lacking
construct (Figure 3B, lanes 17–20) indicated that seleno-
protein synthesis was indeed SECIS-dependent.
This unexpected result raised the possibility that the
distinctive binding aﬃnities of dSBP2 for SECIS RNAs
could originate from the diﬀerent apical secondary struc-
tures classifying form 1 and form 2 SECIS RNAs
[Figure 4; (6,7)]. To answer the question, we decided to
swap the apexes between both forms of SECIS RNAs to
yield chimeric SECIS RNAs: a PHGPx-ApSelN SECIS
with the apex of SelN SECIS, and a SelN-ApPHGPx
SECIS with that of PHGPx SECIS (Figure 4).
The binding of dSBP2 and hSBP2 was tested by gel-shift
assays (data expressed as Kd values in Table 1).
Surprisingly, the apex of the form 1 SECIS did not lead
to abolition of dSBP2 binding to the chimeric PHGPx-
ApSelN SECIS while the SelN-ApPHGPx SECIS, carry-
ing the stem of SelN and the apex of the form 2 PHGPx,
did not confer to dSBP2 the ability to bind. Indeed, the
apex is not responsible for the distinctive binding of
dSBP2 since replacing the genuine apexes by an ultrastable
UUCG tetraloop in PHGPx and SelN SECIS did not
modify the eﬀects induced by apex swapping (data not
shown). These results suggest that the diﬀerence between
forms 1 and 2 SECIS may not rely solely on distinct apical
structures (6) but that other determinants/discriminants
could also exist elsewhere in the SECIS RNA 2D and/or
3D structures.
Point mutationsin anewly mappedlysine-rich
domainin hSBP2affect bindingto form 1but
notto form2SECIS RNAs
We hypothesized that a domain(s) in SBP2 might be
responsible for the diﬀerential SECIS binding. First, we
re-examined in-depth the boundaries of the hSBP2 RNA-
binding domain. A series of N- and C-terminal deletions
was performed in the construct encoding hSBP2 344–854
(Figure 5A). The resulting 6  His-tagged hSBP2 pro-
teins were expressed in E. coli, puriﬁed and their binding
abilities assessed by gel-shift assays with SelN (form 1)
and PHGPx (form 2) SECIS RNAs (Figure 5A). Lack
of binding of the 344–674 hSBP2 protein resulted from
amputation of the major part of the previously mapped
L7Ae RNA-binding module (20–22,25). However, the loss
of binding manifested by hSBP2 proteins 545–854, 625–
854 and 674–854 revealed that a region outside of the
L7Ae module is also crucial. More precisely, this other
domain should lie between positions 525 and 545 since
hSBP2 525–854 retained SECIS binding activity.
Interestingly, this region contains the conserved block of
amino acids of highest sequence identity revealed by our
alignments (Figure 1, residues 517–544). To characterize
this domain with more accuracy, we carried out alanine
scanning mutations in construct hSBP2 344–854 from
positions K516 to R546, in groups of three amino acids
except K516 which was singly mutated (Figure 5B). The
mutant proteins were expressed in E. coli, puriﬁed and
screened by gel-shift for their ability to bind the GPx1
and SelN form 1 and the PHGPx form 2 SECIS RNAs.
Mutations that yielded the most signiﬁcant impacts on Kd
values are given in Figure 5C. While the mutations did not
have a major eﬀect on binding to the form 2 PHGPx
SECIS (Kd values ranging from 480 to 580nM, not deviat-
ing too much from the 350nM wt value), the aﬃnity
dropped dramatically for form 1 SECIS and more partic-
ularly for GPx1 SECIS: a gradual augmentation of
the Kd values was observed which peaked to a maximum
for the Ala535–537 mutation, and dropped to near
wt values for Ala541–543. For Ala535–537, the Kd
increase for GPx1 SECIS was 4.5-fold the wt value.
In conclusion, the most severely aﬀected sequence was
526-AKKPTSLKKIILKER-540 and major eﬀects were
Nucleic Acids Research,2009, Vol.37, No. 7 2131provoked by mutations of 532-LKK-534 and 535-IIL-537,
the latter providing a culminating eﬀect.
Taken together, sequence comparisons, deletion and
alanine scanning mutagenesis enabled us to identify a
domain in hSBP2, residing between K516 and K544,
that diﬀers from the already known L7Ae module. We
named it the K-rich domain because of its relatively
high content in lysine residues (34%; 10 lysines out of 29
residues). This domain contains amino acids 526–540
essential for binding to form 1 SECIS RNAs but its muta-
tion did not aﬀect form 2 SECIS recognition.
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Figure 3. dSBP2 has distinct aﬃnities for form 1 and 2 SECIS RNAs. (A) Gel shift assays were performed between in vitro transcribed
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PHGPx (form 2), GPx1 and SelN (form 1) SECIS RNAs and either puriﬁed dSBP2 or hSBP2, with the range of protein concentration (nM)
indicated above each gel. Proteins were omitted in lanes 1, 8, 15, 22, 30 and 38. The asterisk in lanes 8–14 is as in Figure 2A. (B) In vitro translation
assay (reticulocyte lysate) of (
35S)-Met-labeled rat glutathione peroxidase 1 (GPx1) from reporter constructs carrying the GPx1 ORF without SECIS
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Table 1. Kd values of hSBP2 and dSBP2 for form 1, form 2 and
chimeric SECIS RNAs
SECIS RNA SBP2 protein
dSBP2 hSBP2
PHGPx (form2) 220 50 320 5
GPx1 (form1) No binding 400 50
SeIN (form1) nd 340 15
PHGPx-APSeIN 230 30 530 120
SeIN-ApPHGPx No binding 470 40
Kd SD (nM)
2132 Nucleic Acids Research, 2009, Vol. 37,No. 7The same mutations inthe K-rich domain affecting
SBP2 bindingto form 1SECISalso impede interaction
withthe 60Sribosomal subunit
Rat SBP2 has been shown to bind puriﬁed rat 80S ribo-
somes (21,24,44). The down-eﬀects that we observed upon
mutating the K-rich domain prompted us to investigate
whether the same mutations would aﬀect ribosome
binding. More speciﬁcally, we ﬁrst determined which of
the ribosomal subunits, 60S or 40S, was the target for the
full-length hSBP2 (hSBP2 FL). In these andfurther experi-
ments, after incubation with hSBP2, the puriﬁed ribosomal
subunits were loaded onto sucrose gradients in a buﬀer
containing 0.5mM Mg
2+, and the fractions were
analyzed by western blotting with an anti-SBP2 antibody.
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Nucleic Acids Research,2009, Vol.37, No. 7 2133Figure 6A shows a high intensity signal with the 60S but a
very faint one with the 40S subunit (compare lane 2 with
lane 1). Similar results were obtained with 80S ribosomes
incubated with hSBP2 FL under these conditions (data
not shown). Human recombinant ribosomal protein p40
was used as a control since it was recently shown to
be capable of binding 40S subunits (45): it eﬀectively
bound 40S but not 60S subunits (Figure 6A, compare
lane 4 with lane 3). Therefore, we can conclude that
under the conditions used, hSBP2 FL bound to 60S sub-
units in a speciﬁc manner. To identify the hSBP2 domain
required for 60S binding, we tested the eﬀects of the
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Figure 5. Identiﬁcation of the K-rich additional RNA binding domain in hSBP2. (A) N- and C-ter deletion mutants were engineered in the full-
length hSBP2 cDNA to yield the displayed constructs. hSBP2 proteins were puriﬁed and assayed by EMSA for their binding to in vitro transcribed
32P-radiolabeled SelN (form 1) or PHGPx (form 2) SECIS RNAs. (+), binds; ( ) no binding; nd, not determined. (B) Alanine scanning mutagenesis.
Residues 516–546 in the hSBP2 344–854 cDNA were mutated to alanines in groups of three amino acids (with the exception of the single K516A), as
shown above the sequence. Proteins were puriﬁed and assayed by gel shifts with in vitro transcribed
32P-labeled PHGPx, GPx1 or SelN SECIS
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2134 Nucleic Acids Research, 2009, Vol. 37,No. 7hSBP2 deletion mutants ending at 854 and starting at 344,
399, 515, 525 and 545. Truncations until position 515 were
innocuous (Figure 6B, lanes 2–4, compare with lane 1)
whereas removing sequences downstream from 515
(hSBP2 525–854 and hSBP2 545–854; Figure 6B, lanes
5 and 6, respectively) led to complete inhibition of 60S
binding. Next, the alanine scanning mutants were used to
identify the important amino acids. None of the alanine
replacements, from 516 to 525 or 541 to 546, signiﬁcantly
altered the binding of hSBP2 (Figure 6C, compare lanes
3–6 and 12, 13 with lane 2). In contrast, alanine scanning
mutants Ala526–528 to Ala538–540 (Figure 6C, lanes
7–11) provoked a marked drop in binding, mutants
Ala529–531 and Ala532–540 inducing an almost complete
abolition of binding (lanes 8 and 9).
The two sets of mutagenesis experiments identify hSBP2
amino acids located between A526 and R543 that are cru-
cial for both 60S ribosomal subunit interaction and to
provide aﬃnity to form 1 SECIS RNAs.
Swappingfive amino acids in thelysine-rich domain
between D. melanogaster and hSBP2 reversedthe
affinitytoward form 1or form 2SECISRNAs
Multiple sequence alignments of 26 vertebrate, one echi-
noderm (sea urchin) and 13 insect SBP2 (12 Drosophila
and the Anopheles gambiae mosquito) amino acid
sequences were performed to obtain information about
the evolutionary conservation of the K-rich domain, align-
ing sequences corresponding to hSBP2 positions 515–547
(Figure 7). This highlighted the sequence conservation
517-KGKXXRXXPKXKKXTXLKXXI/VXXXR-540
(numbering of hSBP2). However, inspection of non-
conserved residues revealed a dichotomy. In particular,
the sequence 535-I/VILKE-539 is replaced by SVRVY in
dSBP2, and shows less conservation across the 12
Drosophila species and the Anopheles mosquito than
between other SBP2s. The only similar amino acid
is I536 in hSBP2 which is replaced by a valine residue
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Figure 6. Human SBP2 interacts with the 60S ribosomal subunit. (A) Detection of hSBP2 in sucrose gradient fractions of 60S and 40S ribosomal
subunits. TCA-precipitated fractions were resolved by SDS–PAGE and assayed by western blot with an anti-hSBP2 antibody (lanes 1 and 2). hSBP2
FL is the full-length human SBP2, p40 (lane 4) a 40S ribosomal subunit protein used as the control. (B) hSBP2 deletion mutant proteins were
assayed for ribosome binding. Fractions containing 60S bound hSBP2 were treated as in (A). Nomenclature as in (A) and Figure 5A. The lower
panel (input proteins) is a western blot showing that the mutant proteins were indeed expressed and detectable by the anti-SBP2 antibody. The arrow
points to a cross-reaction product arising from an E.coli protein. (C) The 60S-bound alanine scanning mutant proteins (shown in Figure 5B) were
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Nucleic Acids Research,2009, Vol.37, No. 7 2135in Drosophila. We asked whether this ﬁve amino acid
change (residues 535–539) between hSBP2 and dSBP2
could be responsible for the inability of dSBP2 to bind
form 1 SECIS RNAs. To test this possibility, we swapped
the hSBP2 IILKE for the corresponding dSBP2 SVRVY
sequence, and vice versa, to yield dSBP2-IILKE and
hSBP2-SVRVY. The binding activities to form 1 and 2
SECIS RNAs of the puriﬁed chimeric SBP2 proteins
were measured by gel-shift assays. Verifying our predic-
tion, dSBP2-IILKE gained the ability to bind the GPx1
and SelN form1 SECIS RNAs (Figure 8A, lanes 10–16
and 18–24, respectively), the aﬃnity for SelN SECIS
being higher than for GPx1 (Kd=200nM versus Kd>
1500nM for GPx1; Table 2). The binding aﬃnity to
form 2 PHGPx (Figure 8A, lanes 2–8) even increased by
a factor of ﬁve with a Kd=40nM (Table 2) versus 220nM
for the wt dSBP2 (Table 1). Conversely, the ﬁve amino acid
swappingled hSBP2-SVRVY tocompletely looseitsability
to bind GPx1 and SelN SECIS (Figure 8B, lanes 10–16 and
18–24, respectively), and modiﬁed moderately (by a factor
516 546 human SBP2
vertebrates 
535 539
Echinoderm
insects
Figure 7. Alignment of the K-rich domain in 26 vertebrate, one echinoderm (sea urchin) and 13 insect (12 Drosophila and the mosquito Anopheles
gambiae) SBP2 sequences. The numbering is that of hSBP2. The red bar above and below sequences refers to the IILKE and SVRVY pentapeptides
mentioned in the text.
2136 Nucleic Acids Research, 2009, Vol. 37,No. 7lower than 2) its binding to form 2 PHGPx SECIS
(Figure 8B, lanes 2–8) with a Kd of 600nM (Table 2)
versus 320nM for the wt hSBP2 (Table 1).
Next, the abilities of the chimeric SBP2 proteins to sup-
port synthesis of the GPx1 selenoprotein, carrying distinct
SECIS in the 30UTR of its mRNA, were veriﬁed in rabbit
reticulocyte lysate. With the form 2 PHGPx SECIS,
Figure 8C shows that the amount of the synthesized repor-
ter was not signiﬁcantly altered whether wt dSBP2 or
dSBP2-IILKE was employed (value=1.3; Figure 8C,
compare lanes 8–10 with lanes 2–4). However, dSBP2
acquired the ability of supporting GPx1 selenoprotein
synthesis by the simple replacement of SVRVY by the
homologous human IILKE sequence in the swapping
mutant dSBP2-IILKE: this was the case for GPx1
(Figure 8C, lanes 19, 20; compare with the complete
inability of wt dSBP2, lanes 15, 16) and SelN SECIS
(Figure 8C, compare lanes 30–32 with lanes 24–26) which
A
B
PHGPx SECIS
−
dSBP2-IILKE
12345678
SECIS
RNA
complex
75 1500
GPx1 SECIS
−
dSBP2-IILKE
9 1 01 11 21 31 41 51 6
75 1500
SelN SECIS
−
dSBP2-IILKE
17 18 19 20 21 22 23 24
75 1500nM
PHGPx SECIS
75 1500
SECIS
RNA
complex
6 2345 78 1
−
hSBP2-SVRVY
GPx1 SECIS
75 1500
9 1 01 11 21 31 41 51 6
−
hSBP2-SVRVY
SelN SECIS
75 1500nM
17 18 19 20 21 22 23 24
-
hSBP2-SVRVY
(form2) (form1) (form1)
(form2) (form1) (form1)
nM − 120 240
dSBP2
120 240
hSBP2
120 240
dIILKE
120 240
hSVRVY
− 120 240
dSBP2
120 240
hSBP2
120 240
dIILKE
120 240
hSVRVY
60 60 60 60
123456789 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 2 0 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 3 0 3 1 3 2 3 3 3 4 3 5
PHGPx
SECIS
GPx1
GPx1
SECIS
GPx1
SelN
SECIS
GPx1
− 120 240
dSBP2
120 240
hSBP2
120 240
dIILKE
120 240
hSVRVY
60 60 60 60
dSBP2 hSBP2 dIILKE hSVRVY dSBP2 hSBP2 dIILKE hSVRVY dSBP2 hSBP2 dIILKE hSVRVY
11 1.3 0.25 0 1 + 0.14 11 2.5 0.45
-
C
−
Figure 8. Reversed SECIS RNA binding properties provided by swapping ﬁve amino acids between Drosophila and human SBP2s. (A) Increasing
concentrations (75–1500nM) of puriﬁed dSBP2 carrying the human SBP2 IILKE sequence (dSBP2-IILKE) were assayed with the indicated form 2 or
form 1
32P-labeled SECIS RNAs. No protein was added in lanes 1, 9, 17. (B) The same experiments were carried out with the hSBP2 containing the
D.melanogaster SVRVY sequence (hSBP2-SVRVY). (C) In vitro translation assay (reticulocyte lysate) of (
35S)-Met-labeled rat glutathione peroxidase
1 (GPx1) from reporter constructs carrying the GPx1 ORF with either the PHGPx, GPx1 or SelN SECIS RNAs in the 30UTR. Rabbit reticulocyte
lysate was supplemented with puriﬁed dSBP2, dSBP2-IILKE (dIILKE), hSBP2 or hSBP2-SVRVY (hSVRVY) at the indicated concentrations
(nM); SBP2 proteins were omitted in lanes 1,14,23. Translation products were treated as in Figure 2B. Values (expressed relative to dSBP2 or
hSBP2 set as 1, or 0 for dSBP2 in lanes 15, 16) resulted from the mean of the values obtained with two to three protein concentrations in two to
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Nucleic Acids Research,2009, Vol.37, No. 7 2137showed a 2.5-fold gain. In contrast, introduction of the
Drosophila SVRVY sequence instead of IILKE in hSBP2
(hSBP2-SVRVY) provided an almost total (14% residual)
or partial (45% residual) inhibition of selenoprotein
synthesis when assayed with the form 1 SelN and GPx1
SECIS, respectively (Figure 8C; compare lanes 33–35 to
lanes 27–29; lanes 21–22 with lanes 17, 18). Tested with
the form 2 PHGPx SECIS, hSBP2-SVRVY led to a
0.25-fold drop of the value obtained with wt hSBP2
(Figure 8C, compare lanes 11–13 with lanes 5–7). This
was unexpected but this ﬁnding nevertheless correlated
with the data shown in Figure 8A and B and Table 2 estab-
lishing a loss of aﬃnity between this chimeric SBP2 and the
PHGPx SECIS (the Kd increased by a factor 2). At present,
we are unable to explain why hSBP2-SVRVY did not
retain close to wild-type properties in gel-shift and seleno-
protein synthesis assays with form 2 SECIS RNA.
Notwithstanding, this set of experiment was globally in
line with the in vitro EMSA data shown in Figure 3B and
Figure 8A and B and the Kd values in Tables 1 and 2.
We conclude from these experiments that the IILKE
sequence confers the ability to bind form 1 SECIS RNAs.
DISCUSSION
SBP2 plays a central role in selenoprotein synthesis
by binding to SECIS hairpins in the 30UTR of selenopro-
tein mRNAs. Earlier domain dissection of the human and
rat SBP2 established that the C-terminal 2/3 are involved
in SECIS and ribosome binding as well as selenocysteine
incorporation while no function has been attributed so
far to its N-terminal part, which is dispensable for seleno-
protein synthesis in reticulocyte lysate (20–22,24).
In this work, we have isolated and functionally character-
ized a bona ﬁde dSBP2 that speciﬁcally lacks the region
homologous to the N-terminus of vertebrate SBP2. In
addition, we report the identiﬁcation in human SBP2 of
a lysine-rich (K-rich) domain that is essential for SECIS
binding, point mutations therein aﬀecting form 1 but not
form 2 SECIS binding. Sequence comparisons established
that the K-rich domain is encountered in all the
SBP2s analyzed (this work and data not shown). In the
D. melanogaster K-rich domain, a ﬁve amino acid
sequence diﬀerence renders Drosophila SBP2 incapable
of binding form 1 SECIS RNAs with high aﬃnity.
Exchanging this sequence with that of hSBP2 enabled
binding of the insect SBP2 to form 1 SECIS but impaired
that of hSBP2. Moreover, we found that the K-rich
sequence is also crucial for the binding of hSBP2 to the
60S ribosomal subunit.
The insect SBP2 is 313 amino acids long, a little less
than a third of the mammalian counterpart. Drosophila
SBP2 is shorter at the C-terminus and a small internal
deletion removed positions corresponding to hSBP2
565–689 (Figure 1). However, the lack of the N-terminal
region corresponding to hSBP2 1–427 accounts for most
of its reduction in size. That selenoprotein synthesis can be
achieved in an organism lacking this domain corroborates
the ﬁnding that it is dispensable in mammalian SBP2
under the experimental conditions used (25). Although
one cannot exclude the possibility that this segment of
SBP2 is encoded by a separate gene in insects, this appears
unlikely because a search in the Drosophila genomes failed
to ﬁnd signiﬁcant sequence similarity to the vertebrate
N-terminal region (data not shown). What might then
be the function of the N-terminal extension in higher
eukaryotes? Several possibilities exist that would pertain
to a more complex selenoprotein synthesis mechanism in
higher eukaryotes: (i) the N-terminal extension could par-
ticipate in ﬁne-tuning selenoprotein expression with a
direct or indirect role in the SBP2 nuclear/cytoplasmic
shuttling, as it contains a nuclear localization signal (46);
(ii) we established by structure prediction and experimen-
tal data that SBP2 is an Intrinsically Disordered Protein
and that the N-terminal extension is widely unstructured
(Olieric eta l ., manuscript in preparation). It is very pos-
sible that this region acquires its proper folding in the
presence of yet to be discovered protein partners, consis-
tent with the role of the Hsp90 chaperone and co-chaper-
ones in the folding and assembly of proteins bearing an
L7Ae RNA-binding module (47) and (iii) ﬁnally, the N-
terminal domain could be involved in an SBP2 function
diﬀerent from selenocysteine incorporation, as inferred
very recently from the ﬁnding that several SBP2 isoforms
arise from splice variants in the N-terminal region (48).
We found a region in hSBP2, the K-rich (lysine-rich)
domain 516-KKGKQREIPKAKKPTSLKKIILKERQ
ER-543, that is essential for SECIS binding. This sequence
is highly conserved across vertebrates and is distinct from
the L7Ae RNA-binding module which is therefore insuf-
ﬁcient on its own to provide SECIS recognition.
Surprisingly, however, alanine scanning mutagenesis of
sequence 516–543 manifested adverse eﬀects on SECIS
binding. While it did not signiﬁcantly prohibit binding
to form 2, dramatic eﬀects were observed on form 1, espe-
cially when altering the sequence 526-AKKPTSLKKII
LKER-540 and most prominently 532-LKKIIL-537
which profoundly disabled SBP2.
A multiple sequence alignment identiﬁed KGKTRLD
PKKKITRLKKSVRVYR (D. melanogaster sequence) as
the homolog of the human K-rich domain. This sequence
analysis highlighted a characteristic feature distinguishing
the insect and other K-rich domains, i.e. the ﬁve amino-
acid substitution I/VILKE in vertebrates to SVRVY in
D. melanogaster. dSBP2 can bind Drosophila and mam-
malian form 2 SECIS RNAs but was unable—or with very
low aﬃnity—to bind form 1 SECIS RNAs, consistent
with Drosophila having selenoprotein mRNAs with
form 2 SECIS exclusively (8,31). The IILKE/SVRVY
Table 2. Kd values of chimeric Drosophila and human SBP2 for form 1
and 2 SECIS RNAs
SECIS RNA SBP2 protein
dSBP2-IILKE hSBP2-SVRVY
PHGPx (form2) 40 6 600 45
GPx1 (form1) >1500 No binding
SeIN (form1) 200 10 nd
Kd SD (nM)
2138 Nucleic Acids Research, 2009, Vol. 37,No. 7swapping experiment enabled dSBP2 to bind form 1
SECIS but led hSBP2 to loose this ability. It is very unli-
kely that the SVRVY sequence per se is inhibitory to form
1 binding since replacement of IIL and KER by alanines
in hSBP2 yielded the same down eﬀect as introduction of
SVRVY in hSBP2. It seems more plausible that the ability
to bind form 1 SECIS requires the occurrence of IILKE
because of its diﬀerent amino-acid composition versus
SVRVY, giving rise to a diﬀerent charge and hydropho-
bicity. The SBP2 functional RNA-binding domain
(526–777 in humans) consists therefore of two subdo-
mains, the K-rich (this work) and the previously charac-
terized conserved L7Ae module extending from Arginine
672 to Isoleucine 749 (20,49). The intervening sequence
exhibits less conservation with the exception of the
624-IHSRRFR-630 block (positions relative to human
SBP2). Bubenik and Driscoll (22) reported in rat SBP2
the existence of a bipartite RNA binding domain in
which R531 (R540 in hSBP2) appeared important for dis-
criminating forms 1 and 2 SECIS hairpins. Indeed, this
arginine is universal in SBP2 (Figure 7) and a mutation
to glutamine, described in SBP2 patients with thyroid dys-
functions, impaired binding to the form 1 SECIS of the
iodothyronine deiodinase mRNA (50). However, we did
not observe such a dramatic eﬀect of the R540 mutation in
human SBP2 since the Ala 538–540 mutation only mildly
aﬀected form 1 binding.
Additionally, and very interestingly, we showed the
importance of that same 526-AKKPTSLKKIILKER-
540 sequence for binding to the 60S ribosomal subunit.
These ﬁndings establish the ability of SBP2 to stably bind
the 60S subunit and the identiﬁcation of the PTSLKK
motif that contributes in a very important manner to the
binding. While this work was in progress, Donovan et al.
(51) reported in rat SBP2 the identiﬁcation of the addi-
tional domain SID, required for SECIS and 80S ribosome
binding. The boundaries of the SID are similar to those we
delineated for the K-rich domain but the authors did not
report a distinctive eﬀect of the SID on form 1 or form 2.
Moreover, the mutation of the IILKE sequence by these
authors signiﬁcantly aﬀected binding to form 2 SECIS, in
contrast to our alanine scanning and swapping experi-
ments. Also, we determined by sucrose gradient centrifu-
gation that SBP2 interacts with the 60S but not the 40S
ribosomal subunit. This is consistent with a proposal that
SBP2 could bind the 28S ribosomal RNA (24). Lastly, our
ﬁnding that the same amino acids in the K-rich domain
are involved in SECIS RNA and 60S ribosomal subunit
recognition strengthens the model establishing that SBP2
cannot bind both simultaneously (44).
Worthy of note is that SBP2, with two domains crucial
for SECIS binding, is set apart from the other proteins of
the L7Ae family which are shorter and for which the L7Ae
domain is itself suﬃcient to ensure speciﬁc interactions
with the cognate RNA (11,18,19,52,53). In a previous
work, we provided a very precise deﬁnition of the RNA-
binding speciﬁcity of hSBP2 (23). In particular, we identi-
ﬁed nucleotide determinants in the SECIS RNA that are
unique to SBP2 among the L7Ae family members: while
the 15.5kD and L7Ae ribosomal proteins have a rather
broad speciﬁcity and can recognize the SECIS RNA,
the converse does not hold true since SBP2 is unable to
bind the U3 snoRNA or the archaeal sRNA (23,54). As a
matter of fact, footprinting experiments and interference
of binding established the requirement of helix I and inter-
nal loop 1 in SECIS RNAs for SBP2 recognition (23,55).
These structural features are idiosyncratic to SECIS
RNAs and therefore not found in other Kink-turn con-
taining RNAs, leading to our proposal that SECIS hair-
pins contain a Kink-turn like rather than a canonical
Kink-turn motif (14). We therefore propose a model ratio-
nalizing the necessity of two domains in SBP2 for complex
formation with the SECIS RNA: (i) a restricted number of
amino acids in the L7Ae module establish contacts with
the guanine bases of the G.A/A.G base pairs as in other
L7Ae proteins, and the conserved U in the SECIS non-
Watson-Crick quartet (11,20); (ii) the lysines in the K-rich
domain contribute positive charges for electrostatic inter-
actions with the phosphates of the SECIS-speciﬁc struc-
tural features and thus increase the aﬃnity of SBP2 for
SECIS RNAs. In this domain, the amino acid composi-
tion of the IILKE sequence could have a direct impact on
SECIS binding or indirectly lead to an L7Ae conforma-
tional change allowing form 1 SECIS recognition.
Validation of these models deﬁnitely requires that the
crystal structure of the SECIS RNA-SBP2 complex be
solved.
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